COVID-19大流行对儿科患者群体产生的二级影响
Lael M Yonker1,2, David Dredge1,3, Alasdair Munro4,5
1Harvard Medical School, Boston, MA, USA.
Expert review of anti-infective therapy
|October 14, 2025
概括
在急性感染之外,COVID-19对儿童和青少年构成长期健康风险. 本综述探讨了儿科患者中MIS-C,长期Covid和神经复杂症等急性后效应.
科学领域:
- 儿科健康 儿科健康
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- SARS-CoV-2 (COVID-19) 的长期健康后果在成年人中得到了认可,但在儿童和青少年中未得到认可.
- 儿童群体面临着COVID-19独特的二级后急性影响.
研究的目的:
- 审查COVID-19对儿科患者的二级后急性影响.
- 概述与SARS-CoV-2感染有关的儿科临床实践中遇到的常见情景.
主要方法:
- 文献综述和对儿童急性后COVID-19影响的当前知识的综合.
- 分析临床情景,包括儿童多系统炎症综合征 (MIS-C),长期Covid和神经/自身免疫并发症.
主要成果:
- 常见的后急性情景包括MIS-C,长期Covid,神经和自身免疫并发症.
- 从生物学,流行病学和公共卫生的角度来看,SARS-CoV-2感染会影响儿科健康.
- 非药物干预有相关的流行病学和公共卫生后果.
结论:
- SARS-CoV-2 对儿童健康有复杂的二级影响,需要多学科干预.
- 优先资助监测,预防和研究后急性病毒并发症至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242
Drug Dosing: Infants and Children
253
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
253
Bullying
8.8K
A modern form of aggression is bullying. As you learn in your study of child development, socializing and playing with other children is beneficial for children’s psychological development. However, as you may have experienced as a child, not all play behavior has positive outcomes. Some children are aggressive and want to play roughly. Other children are selfish and do not want to share toys. One form of negative social interactions among children that has become a national concern is...
8.8K


